Purpose: To determine the factors affecting trabeculectomy success. Design: Retrospective analysis of 2 randomized controlled trials comparing an antibody against transforming growth factor β2 (TGF-β2) with vehicle (placebo) for prevention of fibrosis after trabeculectomy, in which there was no significant difference between the treatment groups. Participants: Data were from patients (n = 726) with a diagnosis of primary open-angle glaucoma, chronic angle-closure glaucoma, pseudoexfoliative glaucoma, or pigmentary glaucoma (PG) who had an intraocular pressure (IOP) > 21 mmHg and visual field or optic disc changes characteristic of glaucoma and were taking the maximum tolerated dose of medication before trabeculectomy. Methods: Patients had trabeculectomy and 4 subconjunctival injections of a human monoclonal antibody to TGF-β2 (CAT-152) or a placebo. The definition of trabeculectomy success in the protocols was an IOP between 6 and 16 mmHg inclusive at months 6 and 12. Analyses of success used factors identified by ophthalmic experts. Main Outcomes Measures: Covariates analyzed included patient age, black race, gender, time since diagnosis, primary diagnosis, country, diabetes, mean defect, cup-to-disc (C/D) ratio, suture type, anesthetic, flap type, IOP at listing for surgery, suture release/lysis, needling, reformed anterior chamber, wound leak, severe bleb vascularity, and bleb microcysts. Results: A stepwise logistic regression model found the following predictors of treatment success: PG (odds ratio [OR], 4.11; 95% confidence interval [CI], 1.41–11.99), high C/D ratio (OR, 2.84; 95% CI, 1.15–6.99), and use of a corneal traction suture (OR, 1.67; 95% CI, 1.09–2.56). A negative relationship was found for black race (OR, 0.28; 95% CI, 0.13–0.62); treatment in France (OR, 0.35; 95% CI, 0.17–0.70), Sweden (OR, 0.17; 95% CI, 0.05–0.58), Spain (OR, 0.37; 95% CI, 0.21–0.68), Poland (OR, 0.53; 95% CI, 0.32–0.88), or Hungary (OR, 0.14; 95% CI, 0.06–0.34); and suture release/lysis (OR, 0.34; 95% CI, 0.22–0.53). The effect of needling was marginally statistically significant (OR, 0.56; 95% CI, 0.31–1.01). Conclusions: Successful trabeculectomy outcome was associated with PG, higher C/D ratio, and corneal traction suturing. Factors associated with surgical failure were black race and suture release/lysis. Intercountry differences also were observed.

Factors affecting the outcome of trabeculectomy. An analysis based on combined data from two phase III studies of an antibody to transforming growth factor beta-2, CAT-152.

MARCHINI, Giorgio;CERUTI, Piero;
2007

Abstract

Purpose: To determine the factors affecting trabeculectomy success. Design: Retrospective analysis of 2 randomized controlled trials comparing an antibody against transforming growth factor β2 (TGF-β2) with vehicle (placebo) for prevention of fibrosis after trabeculectomy, in which there was no significant difference between the treatment groups. Participants: Data were from patients (n = 726) with a diagnosis of primary open-angle glaucoma, chronic angle-closure glaucoma, pseudoexfoliative glaucoma, or pigmentary glaucoma (PG) who had an intraocular pressure (IOP) > 21 mmHg and visual field or optic disc changes characteristic of glaucoma and were taking the maximum tolerated dose of medication before trabeculectomy. Methods: Patients had trabeculectomy and 4 subconjunctival injections of a human monoclonal antibody to TGF-β2 (CAT-152) or a placebo. The definition of trabeculectomy success in the protocols was an IOP between 6 and 16 mmHg inclusive at months 6 and 12. Analyses of success used factors identified by ophthalmic experts. Main Outcomes Measures: Covariates analyzed included patient age, black race, gender, time since diagnosis, primary diagnosis, country, diabetes, mean defect, cup-to-disc (C/D) ratio, suture type, anesthetic, flap type, IOP at listing for surgery, suture release/lysis, needling, reformed anterior chamber, wound leak, severe bleb vascularity, and bleb microcysts. Results: A stepwise logistic regression model found the following predictors of treatment success: PG (odds ratio [OR], 4.11; 95% confidence interval [CI], 1.41–11.99), high C/D ratio (OR, 2.84; 95% CI, 1.15–6.99), and use of a corneal traction suture (OR, 1.67; 95% CI, 1.09–2.56). A negative relationship was found for black race (OR, 0.28; 95% CI, 0.13–0.62); treatment in France (OR, 0.35; 95% CI, 0.17–0.70), Sweden (OR, 0.17; 95% CI, 0.05–0.58), Spain (OR, 0.37; 95% CI, 0.21–0.68), Poland (OR, 0.53; 95% CI, 0.32–0.88), or Hungary (OR, 0.14; 95% CI, 0.06–0.34); and suture release/lysis (OR, 0.34; 95% CI, 0.22–0.53). The effect of needling was marginally statistically significant (OR, 0.56; 95% CI, 0.31–1.01). Conclusions: Successful trabeculectomy outcome was associated with PG, higher C/D ratio, and corneal traction suturing. Factors associated with surgical failure were black race and suture release/lysis. Intercountry differences also were observed.
glaucoma; trabeculectomy; outcome; patients; CAT-152
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11562/324580
Citazioni
  • ???jsp.display-item.citation.pmc??? 16
  • Scopus 57
  • ???jsp.display-item.citation.isi??? 115
social impact